NCT04949529View on ClinicalTrials.gov

Falls: A Marker of Preclinical AD

CompletedOBSERVATIONAL
Enrollment

355

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
FallAlzheimer Disease
Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Washington University School of Medicine

OTHER

NCT04949529 - Falls: A Marker of Preclinical AD | Biotech Hunter | Biotech Hunter